ZYBERNO
Stock Report
Updated Sep 1, 2026

GoHealth, Inc. (GOCO)

NASDAQ

$0.34

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
13.0/100
POOR BUSINESS
GoHealth, Inc. (GOCO) scores 13/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-1,392.4%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-297.4%)
Return on Capital (Capital Efficiency):CRITICAL (-69.2%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

GoHealth, Inc. (GOCO) stock report — Zyberno Score 13/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, GOCO generated -$107.76M in Owner Earnings. Capital was deployed as follows: $5.20M invested in capital expenditures. Reinvestment rate: 18.3%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.34
Market Cap:$5.46M

Valuation Multiples (2)

P/S Ratio:0.04x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$624.52M

Price Action & Momentum (1)

% of 52-Week High:6.1%
B. Profitability Assessment

Return Metrics (5)

ROA:-27.3%
Reinvestment Rate:18.3%
Fundamental Growth Rate (g):-12.7%

Margin Analysis (3)

Operating Margin Ttm:-297.4%
Net Margin Ttm:-189.7%
Ebitda Margin:-218.7%

TTM Performance (3)

Gross Margin Ttm:57.3%
Operating Margin Ttm:-297.4%
Net Margin Ttm:-189.7%

Yield Metrics (2)

Earnings Yield:-$6.53K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-253.6%
Latest Earnings Filed:2026-05-18

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-36.7%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):-35.9%
Operating Cash Flow Growth Rate (Linear):-38.4%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:2.03x
Quick Ratio:2.03x
Cash Ratio:0.31x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-4.04x
Times Interest Earned:-4.04

Capital Structure (4)

Working Capital:134,668,000.00
Cash And Cash Equivalents:39,879,000.00
Long Term Debt:$650.76M
Net Debt:$619.06M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $152.79M
Linear Growth: -36.7%
📊 Click to view full GOCO Revenue analysis & methodology →
Cost Of Revenue Ttm:$65.17M

Profitability Breakdown (2)

Gross profit TTM: $87.62M
Linear Growth: -42.9%
📊 Click to view full GOCO Gross Profit analysis & methodology →
-$454.36M

Bottom Line Performance (3)

-$289.89M
Income Before Tax:-$557.83M
Ebitda Ttm:-334,194,000.00

Operating Expenses (5)

Operating Expenses:607,151,000.00
R And D Expense:0.00
Sga Expense:89,826,000.00
Income Tax Expense:-$3.73M
Interest Expense:102,152,000.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:754.0%
Ebitda Margin:-218.7%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$917.92M
Current Assets:$264.90M
Ppe Net:0.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:1,044,616,000.00
Current Liabilities:130,235,000.00
Long Term Debt:$650.76M
Short Term Debt:$8.18M

Equity & Capital (3)

Equity:-$126.70M
Retained Earnings:-$717.51M
Common Stock:1,000.00

Working Capital Items (3)

Accounts Receivable:1,000.00
Inventory:0.00
Accounts Payable:8,467,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:2,568,000.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: -$102.56M
Linear Growth: -38.4%
Free cash flow TTM: -$107.76M
Linear Growth: -35.9%
📊 Click to view full GOCO Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:$0.00
Capital Expenditures Ttm:5,200,000.00

Financing Activities (3)

Financing Cash Flow:-$25.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:120,170,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-22.01
-$22.01
Earnings Per Share Ttm:-$17.90

Revenue & Cash Per Share (2)

Sales Per Share Ttm:9.43
Operating Cash Flow Per Share:-$7.53

Book Value & Capital (2)

Book Value Per Share:-$7.82
Cash Per Share:2.46

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.14x
Working Capital Turnover Ttm:1.13x

Receivables Management (2)

Receivables Turnover Ttm:152,787.00x
Days Sales Outstanding Ttm:0.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:47.42
Cash Conversion Cycle:-1,046.42
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00
Quality Score:25.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$107.76M

Damodaran Growth Analysis (2)

Reinvestment Rate:18.3%
Fundamental Growth Rate (g):-12.7%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-36.7%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):-35.9%
Operating Cash Flow Growth Rate (Linear):-38.4%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-42.9%
Book Value Growth Rate (Linear):-25.5%
C. Company Profile & Context

Corporate Information (6)

Symbol:GOCO
Company Name:GoHealth, Inc.
Sector:Unknown
Industry:Insurance Agents, Brokers & Service
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:16.20M
Shares Outstanding Basic:16.20M
Shares Outstanding Diluted:16.20M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 15:57:30 UTC
Data Timestamp:2026-08-21T18:13:40.941931
Scroll to Top